Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies

Author:

Janssen Cécile1,Mosnier Anne2,Gavazzi Gaëtan34,Combadière Behazine5,Crépey Pascal6,Gaillat Jacques1,Launay Odile7,Botelho-Nevers Elisabeth89

Affiliation:

1. Service de Maladies Infectieuses, Centre Hospitalier Annecy Genevois, Annecy, France

2. Open Rome, Paris, France

3. Service Universitaire de Gériatrie Clinique, CHU Grenoble Alpes, Grenoble, France

4. Laboratoire T-Raig TIMC-IMAG CNRS 5525, Université Grenoble-Alpes, Grenoble, France

5. Center for Immunology and Infectious Diseases, Sorbonne University, Inserm U1135, Paris, France

6. Ecole des hautes études en santé publique, CNRS, Université de Rennes, ARENES - UMR 6051, Recherche sur les services et le management en santé - Inserm U 1309, Rennes, France

7. CIC 14117 Cochin-Pasteur, Université Paris Cité, Inserm, F CRIN-I REIVAC, Paris, France

8. Service d’Infectiologie, Hôpital Nord-CHU Saint Etienne, Saint-Etienne, France

9. CIRI – Team GIMAP, Univ. Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, Saint-Etienne, France

Funder

Sanofi

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. WHO, World Health Organization. Vaccines against influenza: wHO position paper. Weekly Epidemiological Record. 2022 May 13 [accessed 2022 Jun 21]. https://www.who.int/publications-detail-redirect/who-wer9719-185-208.

2. Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22

3. Australian Government Department of health. Australian influenza surveillance report - No 05 - fortnight ending 05 June 2022. Australia: Australian Government Department of Health; 2022. Report No: 05.

4. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries

5. The Incoming Influenza Season — China, the United Kingdom, and the United States, 2021–2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3